接种 COVID-19 疫苗后的中毒性表皮坏死症:病例报告和文献综述。

IF 0.8 Q4 EMERGENCY MEDICINE
Sachin Wali, Shreyas Gutte, Gaurav Pandey, Ajit Kumar, Mohan Gurjar, Jitendra Singh Chahar
{"title":"接种 COVID-19 疫苗后的中毒性表皮坏死症:病例报告和文献综述。","authors":"Sachin Wali, Shreyas Gutte, Gaurav Pandey, Ajit Kumar, Mohan Gurjar, Jitendra Singh Chahar","doi":"10.6705/j.jacme.202406_14(2).0005","DOIUrl":null,"url":null,"abstract":"<p><p>Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 2","pages":"94-97"},"PeriodicalIF":0.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11153313/pdf/","citationCount":"0","resultStr":"{\"title\":\"Toxic Epidermal Necrolysis After COVID-19 Vaccination: A Case Report and Review of Literature.\",\"authors\":\"Sachin Wali, Shreyas Gutte, Gaurav Pandey, Ajit Kumar, Mohan Gurjar, Jitendra Singh Chahar\",\"doi\":\"10.6705/j.jacme.202406_14(2).0005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.</p>\",\"PeriodicalId\":14846,\"journal\":{\"name\":\"Journal of acute medicine\",\"volume\":\"14 2\",\"pages\":\"94-97\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11153313/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of acute medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.6705/j.jacme.202406_14(2).0005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"EMERGENCY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of acute medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6705/j.jacme.202406_14(2).0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

据报道,接种 COVID-19 疫苗后会出现各种皮肤不良反应 (CAR)。这里有一名年过五旬的亚洲男性,在接种 ChAdOx1 nCov-19 疫苗加强剂 10 天后出现皮肤坏死并伴有粘膜受累。根据病程和形态,怀疑是中毒性表皮坏死(TEN)。患者出现呼吸窘迫并被插管,静脉注射了每公斤体重 2 克的免疫球蛋白(IVIG),随后皮损在第四周愈合,患者在重症监护室(ICU)住了 50 天后出院。接种 ChAdOx1nCoV-19 腺病毒载体疫苗的两种成分后出现严重 CAR 的情况非常罕见,病毒载体会导致 T 细胞介导的粒细胞素和粒酶 B 释放,从而导致表皮脱落和呼吸道粘膜受累,引起呼吸衰竭。第一剂和第二剂均无不良反应的患者也可能发生 CAR。支持疗法和预防败血症是治疗的主要手段。虽然静脉注射免疫球蛋白(IVIG)的使用结果不尽相同,但我们的病例使用静脉注射免疫球蛋白(IVIG)获得了成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Toxic Epidermal Necrolysis After COVID-19 Vaccination: A Case Report and Review of Literature.

Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of acute medicine
Journal of acute medicine EMERGENCY MEDICINE-
CiteScore
0.80
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信